Once the domain of science fiction, neurotechnology is a reality with enormous implications for medicine and the digital ...

"Most 'wellness companies' test for specific genes. They will produce a report outlining dietary advice based on your genetic ...

Now the company's on the brink of bankruptcy, it's raised concerns about what will happen to the genetic data it has in its ...

Stock splits are typically viewed as bullish indicators that a company sees more growth is on the horizon. Although nothing ...

DNA testing company 23andMe is in financial crisis, raising questions about what will happen to the data it holds on 15 milli ...

Me helped usher in the era of consumer DNA test kits nearly two decades ago, but has more recently faced a series of setbacks ...

The company’s valuation had dropped from $6 billion in 2021, to under $150 million after going public and when CEO Anne Wojcicki pushed for a plan to buy it and take it private, the board rejected her ...

A spokesperson for 23andMe would not comment to NPR on what will happen to genetic data, except to express the company’s ...

Financial and security chaos at the once-pioneering genetic testing firm has intensified concerns about user data. Here's how ...

The blue-chip board and the startup star had been on a collision course for months. Here’s what really happened.

In 2009, Anne Wojcicki took a decisive step in her role as the leader of 23andMe, the genetic testing company she co-founded ...

Anne Wojcicki, CEO of 23andMe, the struggling DNA testing company, doesn’t think this is the right time to examine her ...